Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

News Opinion Off Script

Off Script: After ISCHEMIA, the Devil Is in the (Design) Details

Ajay Kirtane, MD, SM

November 28, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2019

Todd Neale

October 31, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2019

Shelley Wood

October 01, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

Presentation TCT 2019

The Future in Managing Patients at High Bleeding Risk

Presenter: Elvin Kedhi

September 26, 2019

Presentation TCT 2019

Two Case Presentations Highlighting Relevant Patients

Presenter: David Kandzari

September 26, 2019

Presentation TCT 2019

Onyx One: Results and Implications

Presenter: Azeem Latib

September 26, 2019

Presentation TCT 2019

Why Onyx One?

Presenter: Ajay Kirtane

September 26, 2019

News Conference News TCT 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

L.A. McKeown

September 26, 2019

Presentation TCT 2019

Who is the High Bleeding Risk Patient?

Presenter: Daniel Simon

September 26, 2019

Presentation TCT 2019

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

Presenter: Stephan Windecker

September 26, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

CME

Updates on Onyx ONE

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Stephan Windecker About Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

September 28, 2019

Advertisement

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Off Script: After ISCHEMIA, the Devil Is in the (Design) Details

TCTMD’s Top 10 Most Popular Stories for October 2019

TCTMD’s Top 10 Most Popular Stories for September 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

The Future in Managing Patients at High Bleeding Risk

Two Case Presentations Highlighting Relevant Patients

Onyx One: Results and Implications

Why Onyx One?

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

Who is the High Bleeding Risk Patient?

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Updates on Onyx ONE

Dr. C. Michael Gibson Talks With Dr. Stephan Windecker About Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content